E
EyeYon Medical
Develops and brings to market exclusive medical ophthalmic devices, which offer relief to the unmet clinical needs of millions of patients
About EyeYon Medical
EyeYon Medical is a pioneering company in the field of ophthalmology, specializing in the development and commercialization of innovative therapeutic contact lenses. The company's flagship product, the Hyper-CL lens, is designed to treat corneal edema and other ocular conditions, significantly improving visual acuity for patients. EyeYon Medical operates in the medical device market, primarily serving ophthalmologists and their patients in Europe and the USA, where the product is CE certified and FDA 510k cleared. The business model revolves around the sale of these specialized lenses to healthcare providers and clinics, generating revenue through direct sales and distribution partnerships. The company focuses on providing effective, non-invasive solutions for eye care, aiming to enhance patient quality of life and satisfaction.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Jerusalem, Israel
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 63.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Ophthalmology, medical implants, Eye Diseases, Patient Care, Non-Invasive medical devices and treatments, Optical Technology, Contact Lenses, Spinout, Non-Surgical
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Mar 2021 | $25M | $100M | Rimonci Capital · Diamond BioFund · British Patient Capital · CR-CP Life Science Fund | — |
| SERIES B✓Equity / VC | Mar 2017 | $7.2M | $29M | Pontifax Funds · TriVentures · Rimonci Capital · Gauss Medical | ↗ |
Growth signals
Latest recorded traffic for EyeYon Medical is 3.2K monthly website visits, up 23.1% over the last three months. EyeYon Medical's team declined 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
TriVentures
Pontifax Funds- RCRimonci Capital
Gauss Medical
Series B and later4 investors entered at this stage
Diamond BioFund
British Patient Capital- CFCR-CP Life Science Fund
- GFGlobal health sciences venture fund
Other known investors5 additional known investors
Clarity Health Services
The Hebrew University of Jerusalem
Weizmann Institute of Science- DMDocor International Management
Quark Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EyeYon Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EyeYon Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.